Methylenblue for malaria

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 10 Jun 2009: Trial completed, NCT00917202
  2. 10 Jun 2009: Trial registered, NCT00917202

The trials

NCT00917202: Efficacy of Methylene Blue for Malaria Treatment in Adults of Burkina Faso: Proof of Principle Study in Semi-Immune Adults of Burkina Faso in the Frame of the A8 Project of the SFB 544

State
Completed
Phase
Phase 2
Arms
MB3, MB5, MB7
Results
None posted
  1. 10 Jun 2009: Trial completed
  2. 10 Jun 2009: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.